After big buyout, team looks to lead hepatitis B, NASH drug maker to $100M IPO
September 28, 2020 at 17:53 PM EDT
Much of the team that led Alios — without a "g" — to aa $1.8 billion acquisition now is back with Aligos.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Home | News | Travel | Restaurants | Nightlife | Things To Do | Shopping | Calendar | Directory | Real Estate | Blog | More
|